On August 25, 2021, AIgenDrug signed an MoU with three experts (Dr. Sangsoo Lim, Sungjoon Park, Chang-Yun Cho) from Seoul National University for the development and deployment of an AI drug toxicity prediction model. This MoU is to initiate one year long project funded by AIgenDrug to the three scientist.
AIgenDrug has been conducting the 'AI platform for drug toxicity' project from August 2021. According to this MoU, the AI drug toxicity prediction model will be optimized and the drug toxicity prediction service will be provided through cloud deployment. AIgenDrug is planning to launch the drug toxicity prediction service in the first half of 2022.